ClinicalTrials.gg
RecruitingNCT07052461VeMicUpdated Aug 25, 2026

Association of Microcirculation, Vexus Score and Femoral Vein Doppler in Patients on the ICU After Non-emergency Cardiac Surgery

An observational study in Microcirculatory Diffusion, Microcirculatory Convection Capacity and Venous Congestion, sponsored by University Hospital, Basel, Switzerland. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by University Hospital, Basel, Switzerland · Observational

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the VeMic study is to explore if venous congestion is linked with microcirculatory impairment in elective cardiac surgery patients in the postoperative ICU stay.

Read the detailed description

Cardiac surgery is associated with a significant risk of postoperative complications, including organ dysfunction such as acute kidney injury (AKI). Traditionally, clinical management in the intensive care unit (ICU) has focused on monitoring macrocirculatory parameters-such as blood pressure, cardiac output, and central venous pressure (CVP)-to guide treatment. However, adequate systemic perfusion does not always translate into sufficient tissue oxygenation at the microcirculatory level. Microcirculation, which occurs in the smallest vessels such as capillaries, is where oxygen and nutrients are actually delivered to the cells. Impairment in microcirculatory function can occur even when macrocirculatory values appear normal, leading to what is known as loss of hemodynamic coherence. Despite growing evidence of the clinical importance of microcirculation, routine bedside assessment remains limited due to technical challenges and the lack of easily applicable tools.

While elevated CVP and signs of venous congestion have been linked to worse outcomes such as AKI, the underlying mechanisms remain poorly understood. CVP alone is an imperfect marker for venous stasis and does not reliably predict microcirculatory impairment. Newer ultrasound-based tools-such as the Vexus score and femoral vein Doppler (FVD)-are emerging as promising, non-invasive methods to assess venous congestion at the bedside. However, it is currently unclear whether these sonographic signs of venous congestion are actually associated with impaired microcirculatory function. This knowledge gap limits clinicians' ability to interpret ultrasound findings in the context of microvascular health and to make informed decisions about fluid management and organ perfusion.

The VeMic study aims to investigate whether ultrasound-based indicators of venous congestion correlate with objectively measured microcirculatory impairment in patients admitted to the ICU after non-emergency cardiac surgery. By combining ultrasound assessments with advanced analysis of sublingual microcirculation using handheld vital microscopy and automated software, the study seeks to bridge the gap between macro- and microcirculatory monitoring. The findings may help determine whether these easily accessible ultrasound tools can be used to detect early signs of microvascular dysfunction and guide more targeted, physiology-based interventions in the postoperative setting.

02

Conditions studied

  • Microcirculatory Diffusion
  • Microcirculatory Convection Capacity
  • Venous Congestion
  • Postoperative Cardiac Surgery
  • Fluid Management
  • Haemodynamic Coherence

Browse trials for

Keywords

  • vexus score
  • femoral vein doppler
  • intensive care unit
03

In context

Hyperemia

98 studies on the registry are indexed under Hyperemia; 44 are open to participants now.

This study's planned enrollment of 40 is below the median of 100 across 46 observational studies indexed under Hyperemia.

Browse Hyperemia studies →

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 990 studies on the registry; 189 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients presenting for elective or urgent cardiac surgery. Urgent patients are defined as patients who have not been electively admitted for operation but who require intervention or surgery on the current admission for medical reasons. These patients cannot be sent home without a definitive procedure but do not require immediate emergency surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Elective or urgent (need for definitive procedure during hospitalisation, but not emergency intervention) cardiac surgery

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years
  • Pregnant women
  • Known severe chronic kidney disease (estimated \<15 mL/min per 1.73 m2 or dialysis)
  • Renal or liver transplantation
  • Any known condition interfering with Doppler evaluation of the portal system (including known or suspected cirrhosis or portal vein thrombosis or huge abdominal emphysema).
  • Inability to consent to study
  • Emergency cardiac surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Difference in red blood cell velocity: concested vs non-congested

    Difference in red blood cell velocity (RBCv) between patients grouped as congested (Vexus score of 2 and 3) vs. non-congested (Vexus score of 0 and 1).

    Time frame: 3 measurements:T0 prior surgery, T1 first post-operative day, T2 6 hours after T1

  2. Difference in total vessel density: concested vs non-congested

    Difference in total vessel density (TVD) between patients grouped as congested (Vexus score of 2 and 3) vs. non-congested (Vexus score of 0 and 1).

    Time frame: 3 measurements:T0 prior surgery, T1 first post-operative day, T2 6 hours after T1

  3. Difference in red blood cell velocity: physiologic femoral vein flow vs. pulsatile pattern

    Difference in red blood cell velocity (RBCv) between patients with a physiologic femoral vein flow vs. pulsatile pattern

    Time frame: 3 measurements:T0 prior surgery, T1 first post-operative day, T2 6 hours after T1

  4. Difference in total vessel density between patients with a physiologic femoral vein flow vs. pulsatile pattern

    Difference in total vessel density (TVD) between patients with a physiologic femoral vein flow vs. pulsatile pattern

    Time frame: 3 measurements:T0 prior surgery, T1 first post-operative day, T2 6 hours after T1

Secondary outcomes

  1. Difference in RBCv between patients with different Vexus scores

    Difference in RBCv between patients with a Vexus score of 0 vs. 1 vs. 2 vs. 3

    Time frame: 3 measurements:T0 prior surgery, T1 first post-operative day, T2 6 hours after T1

  2. Difference inTVD between patients with different Vexus scores

    Difference inTVD between patients with a Vexus score of 0 vs. 1 vs. 2 vs. 3

    Time frame: 3 measurements:T0 prior surgery, T1 first post-operative day, T2 6 hours after T1

  3. Difference in microcirculatory reserve capacity: congested non-congested

    Difference in microcirculatory reserve capacity between patients grouped as congested (Vexus score of 2 and 3) vs. non-congested (Vexus score of 0 and 1)

    Time frame: 3 measurements:T0 prior surgery, T1 first post-operative day, T2 6 hours after T1

  4. Difference in microcirculatory reserve capacity: physiologic femoral vein flow vs. pulsatile patern

    Difference in microcirculatory reserve capacity between patients with a physiologic femoral vein flow vs. pulsatile patern

    Time frame: 3 measurements:T0 prior surgery, T1 first post-operative day, T2 6 hours after T1

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07052461
Responsible party
Sponsor
First posted
Jul 4, 2025
Start date
Apr 14, 2026
Primary completion
Jun 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Aug 25, 2026

Study contacts

Gregor Loosen,, MD
Contact
gregormichael.loosen@usb.ch
+41 61 328 40 90
Martin Siegemund, Prof. MD
study chair · University Hospital of Basel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion